FiatLux Imaging leveraged advances in the video gaming industry to develop software for processing 3D medical images, a product made to order for tight budgets.
FiatLux Imaging leveraged advances in the video gaming industry to develop software for processing 3D medical images, a product made to order for tight budgets. With a license price under $3000, Visualize 3D is affordable for "anywhere, anytime" imaging on PC laptops and tablets, possibly even Palm computers, according to the company. RSNA newcomer FiatLux, which was founded only 18 months ago, exhibited the package at RSNA 2008, demonstrating its ability to analyze CT and MR images by taking advantage of DirectX game programming technologies.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.
What Emerging CT Research Reveals About Obesity and Post-Op Survival for Non-Small Cell Lung Cancer
January 29th 2025For those without low skeletal muscle mass on CT and myosteatosis, obese patients have a 23 percent lower risk of death than non-obese patients after undergoing curative resection for non-small cell lung cancer, according to newly published research.